Skip to content

Clinical trials

Observational Macular Degeneration trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Macular Degeneration Phase: Observational Country / region: Australia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20171
20191
20202
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Center for Eye Research Australia3
The University of Queensland2
Bayer1
Genentech, Inc.1
Gyroscope Therapeutics Limited1
Novartis Pharmaceuticals1
University of Wisconsin, Madison1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Macular Degeneration10
Geographic Atrophy2
Anetoderma1
Choroidal Neovascularization1
Diabetic Retinopathy1
Glaucoma1
Retinal Degeneration1
Retinal Diseases1
Retinal Dystrophies1
Retinal Vein Occlusion1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.